
News|Articles|September 10, 2024
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
Author(s)WCG Clinical
The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Trending on Applied Clinical Trials Online
1
Reducing Site Burden Through Better Technology Integration in Clinical Trials
2
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
3
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
4
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
5

.png)



.png)



.png)
.png)
